Reuters logo
BUZZ-Insys Therapeutics Inc: Epilepsy drug gets orphan status
June 25, 2014 / 1:25 PM / 3 years ago

BUZZ-Insys Therapeutics Inc: Epilepsy drug gets orphan status

** Specialty pharmaceutical company’s shares up 5 pct at $30.45 after U.S. FDA granted orphan drug designation to its experimental epilepsy drug

** The company plans to file for an application to start human trials of the drug in the second half of 2014

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below